Eterna Therapeutics (ERNA) - 2019 Q3 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock NTN NYSE American Emerging growth company [ ] FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 Commission file number 001-11460 NTN Buzztime, Inc. (Exact name of registrant as specified in its charter) 1800 ASTON AVENUE, SUITE 100, CARLSBAD, CALIFO ...